Financing, Equity Capital Markets

Inozyme Pharma, Inc.

07/20
|
$128.0 Million
Piper Sandler served as bookrunner for Inozyme Pharma, Inc. on its initial public offering
Sub-Type
IPO
Sub-Sector
Biopharma